CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale CEO sold 3,928 shares at $23.80 ($93,486)
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale EVP, COO, Head of Commercial sold 538 shares at $23.05 ($12,401)
- 4 Open-market sale EVP & General Counsel sold 574 shares at $23.05 ($13,231)
- 4 Open-market sale President sold 1,937 shares at $23.05 ($44,648)
- 4 Open-market sale CEO sold 3,718 shares at $23.05 ($85,700)
- 8-K Event Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 8-K Event Other events
- 4 Open-market sale President sold 2,803 shares at $19.01 ($53,285)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
Page 17 of 70 · 1,382 filings